Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584896 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease
A Phase 3 study, sponsored by Point Biomedical.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1,000
- Enrollment target
NCT00584896: Clinical Trial Phase 3 study, sponsored by Point Biomedical.
NCT00584896 is a Phase 3 study that was terminated before completion, run by Point Biomedical. The registered enrollment target is 1,000 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00584896, a Phase 3 study, was terminated before completion, sponsored by Point Biomedical.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of PB127 with cardiac ultrasound assists in the diagnosis or exclusion of coronary artery disease.
Interventions
- DRUG PB127 for Injectable Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-07 |
| Phase | Phase 3 |
Why NCT00584896 stopped before completion
NCT00584896 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (30% higher).
The record links to 0 conditions, and to 1 intervention - of which PB127 for Injectable Suspension is the first listed.
NCT00584896 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00584896 about?
NCT00584896 is a clinical study titled "Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease". The purpose of this study is to determine if the use of PB127 with cardiac ultrasound assists in the diagnosis or exclusion of coronary artery disease.
What is the current status of trial NCT00584896?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1,000 participants. The study started on 2007-10. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00584896?
The interventions under investigation include: PB127 for Injectable Suspension (DRUG).
Who is sponsoring clinical trial NCT00584896?
This trial is sponsored by Point Biomedical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00584896's enrollment target sits among peer trials
1,000 296th of 2000 higher than 1,689 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia